Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines

Mass vaccination with a safe and effective vaccine may be the best way to control the COVID-19 pandemic. Heterologous prime-boost vaccination with the CoronaVac and AZD1222 vaccines may increase the immunogenicity elicited by either vaccine alone. This study sought to compare the immunogenicity of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Guy, Jungsomsri, Pawornrath, Sangwongwanich, Jirath, Tawinprai, Kriangkrai, Siripongboonsitti, Taweegrit, Porntharukchareon, Thachanun, Wittayasak, Kasiruck, Thonwirak, Nawarat, Soonklang, Kamonwan, Sornsamdang, Gaidganok, Auewarakul, Chirayu, Mahanonda, Nithi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115782/
https://www.ncbi.nlm.nih.gov/pubmed/35323079
http://dx.doi.org/10.1080/21645515.2022.2052525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115782/
https://www.ncbi.nlm.nih.gov/pubmed/35323079
http://dx.doi.org/10.1080/21645515.2022.2052525

Ejemplares similares